Literature DB >> 9621050

Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line.

G P Harrison1, G Miele, E Hunter, A M Lever.   

Abstract

Packaging of type C retrovirus genomic RNAs into budding virions requires a highly specific interaction between the viral Gag precursor and unique cis-acting packaging signals on the full-length RNA genome, allowing the selection of this RNA species from among a pool of spliced viral RNAs and similar cellular RNAs. This process is thought to involve RNA secondary and tertiary structural motifs since there is little conservation of the primary sequence of this region between retroviruses. To confirm RNA secondary structures, which we and others have predicted for this region, disruptive, compensatory, and deletion mutations were introduced into proviral constructs, which were then assayed in a permissive cell line. Disruption of either of two predicted stem-loops was found to greatly reduce RNA encapsidation and replication, whereas compensatory mutations restoring base pairing to these stem-loops had a wild-type phenotype. A GGNGR motif was identified in the loops of three hairpins in this region. Results were consistent with the hypothesis that the process of efficient RNA encapsidation is linked to dimerization. Replication and encapsidation were shown to occur at a reduced rate in the absence of the previously described kissing hairpin motif.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621050      PMCID: PMC110392     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  RNA binding site of R17 coat protein.

Authors:  P J Romaniuk; P Lowary; H N Wu; G Stormo; O C Uhlenbeck
Journal:  Biochemistry       Date:  1987-03-24       Impact factor: 3.162

2.  Structure and molecular weight of the 60-70S RNA and the 30-40S RNA of the Rous sarcoma virus.

Authors:  W F Mangel; H Delius; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

3.  Computer support of DNA sequence analysis.

Authors:  G Osterburg; R Sommer
Journal:  Comput Programs Biomed       Date:  1981 Mar-Jun

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  A thermodynamic and mutational analysis of an RNA purine loop as a protein binding site.

Authors:  S A White; H Li; M E Rauch
Journal:  J Biomol Struct Dyn       Date:  1995-10

7.  cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.

Authors:  J F Kaye; J H Richardson; A M Lever
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy.

Authors:  K G Murti; M Bondurant; A Tereba
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

9.  A molecular clone of HTLV-III with biological activity.

Authors:  A G Fisher; E Collalti; L Ratner; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

10.  A short sequence upstream of the 5' major splice site is important for encapsidation of HIV-1 genomic RNA.

Authors:  H J Kim; K Lee; J J O'Rear
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

View more
  42 in total

1.  Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Authors:  F Jossinet; J C Paillart; E Westhof; T Hermann; E Skripkin; J S Lodmell; C Ehresmann; B Ehresmann; R Marquet
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.

Authors:  Rodney S Russell; Jing Hu; Véronique Bériault; Andrew J Mouland; Michael Laughrea; Lawrence Kleiman; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Rapid purification of RNA secondary structures.

Authors:  Stacy L Gelhaus; William R LaCourse; Nathan A Hagan; Gaya K Amarasinghe; Daniele Fabris
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

6.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

7.  In vitro and in vivo analysis of the interaction between RNA helicase A and HIV-1 RNA.

Authors:  Li Xing; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

8.  Microglia and neurogenesis in the epileptic dentate gyrus.

Authors:  Cong Luo; Yuji Ikegaya; Ryuta Koyama
Journal:  Neurogenesis (Austin)       Date:  2016-09-26

9.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

10.  High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states.

Authors:  Kevin A Wilkinson; Robert J Gorelick; Suzy M Vasa; Nicolas Guex; Alan Rein; David H Mathews; Morgan C Giddings; Kevin M Weeks
Journal:  PLoS Biol       Date:  2008-04-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.